CAS: 417716-92-8 - Lenvatinib
Formula:C21H19ClN4O4
InChI:InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)
InChI key:InChIKey=WOSKHXYHFSIKNG-UHFFFAOYSA-N
SMILES:O=C(N)C1=CC=2C(=NC=CC2OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)C=C1OC
- Synonyms:
- 4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide
- 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide
- 4-{3-Chloro-4-[(Cyclopropylcarbamoyl)Amino]Phenoxy}-7-Methoxyquinoline-6-Carboxamide
- 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-
- E 7080
- Er 203492-00
- Lenvanix
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide
CAS:417716-92-8
Formula:
C21H19ClN4O4
Color and Shape:
Solid
Molecular weight:
426.8530
Ref: AN-AG00379E
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 7 May 2024
Lenvatinib
CAS:417716-92-8
Lenvatinib (E7080) is a multi-target receptor tyrosine kinase inhibitor that inhibits VEGFR1-3, FGFR1-4, KIT, PDGFR, …
Formula:
C21H19ClN4O4
Purity:
99.8000%
Color and Shape:
Solid
Molecular weight:
426.85
Ref: TM-T0520
1g | 635.00 € | |
5mg | 48.00 € | |
10mg | 62.00 € | |
25mg | 96.00 € | |
50mg | 119.00 € | |
100mg | 175.00 € | |
500mg | 430.00 € | |
1ml*10 (DMSO) | 49.00 € |
Estimated delivery in United States, on Tuesday 7 May 2024
Ref: 4Z-L-124001
10mg | To inquire | |
25mg | 479.00 € | |
50mg | 683.00 € | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 May 2024
Ref: 4Z-L-124004
10mg | 2,598.00 € | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 May 2024
Ref: 7W-GW2433
1mg | 241.00 € | |
5mg | 359.00 € | |
10mg | 548.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Lenvatinib-d5
Controlled ProductCAS:417716-92-8
Applications Lenvatinib-d5 is labelled Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor …
Formula:
C21H14D5ClN4O4
Color and Shape:
Light Red
Molecular weight:
431.88
Ref: TR-L329402
1mg | 436.00 € | |
5mg | 1,731.00 € | |
10mg | 3,301.00 € |
Estimated delivery in United States, on Friday 17 May 2024
Lenvatinib
Controlled ProductCAS:417716-92-8
Applications Lenvatinib is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF …
Formula:
C21H19ClN4O4
Color and Shape:
White To Beige
Molecular weight:
426.85
Ref: TR-L329400
5mg | 132.00 € | |
25mg | 526.00 € | |
100mg | 1,368.00 € |
Estimated delivery in United States, on Friday 17 May 2024
Lenvatinib base - Bio-X ™
CAS:417716-92-8
Lenvatinib is a tyrosine kinase inhibitor that is used to treat cancers such as solid …
Formula:
C21H19ClN4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
426.85 g/mol
Ref: 3D-BL164616
10mg | 133.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Lenvatinib base
CAS:417716-92-8
VEGFR2 and VEGFR3 tyrosine kinase inhibitor
Formula:
C21H19ClN4O4
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
426.85 g/mol
Ref: 3D-FC75063
1g | 843.00 € | |
50mg | 176.00 € | |
100mg | 265.00 € | |
250mg | 497.00 € | |
500mg | 663.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024